NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 84 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,409,316 | -18.3% | 445,986 | 0.0% | 0.01% | -23.1% |
Q2 2023 | $1,725,966 | +30.8% | 445,986 | -6.4% | 0.01% | +8.3% |
Q1 2023 | $1,319,708 | +53.9% | 476,429 | 0.0% | 0.01% | +33.3% |
Q4 2022 | $857,572 | -15.1% | 476,429 | 0.0% | 0.01% | -25.0% |
Q3 2022 | $1,010,000 | -24.3% | 476,429 | -3.9% | 0.01% | -20.0% |
Q2 2022 | $1,334,000 | -38.0% | 495,986 | 0.0% | 0.02% | -37.5% |
Q1 2022 | $2,153,000 | -16.2% | 495,986 | 0.0% | 0.02% | -20.0% |
Q4 2021 | $2,569,000 | -15.6% | 495,986 | 0.0% | 0.03% | -21.1% |
Q3 2021 | $3,045,000 | -77.5% | 495,986 | -65.0% | 0.04% | -75.6% |
Q2 2021 | $13,520,000 | – | 1,415,639 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |